Minichromosome maintenance protein 7 in colorectal cancer: Implication of prognostic significance

International Journal of Oncology

Volumn 33, Issue 2, 2008, Pages 245-251

  Nishihara, Keisuke ^a   Shomori, Kohei ^a   Fujioka, Shinji ^a   Tokuyasu, Naruo ^a   Inaba, Aiko ^a   Osaki, Mitsuhiko ^b   Ogawa, Toshihide ^a   Ito, Hisao ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Licensed non proliferating population; Minichromosome maintenance 7; Prognostic factor

Indexed keywords

BETA ACTIN; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 2; MINICHROMOSOME MAINTENANCE PROTEIN 7; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER SURGERY; CELL POPULATION; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR LOCALIZATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; KI-67 ANTIGEN; NUCLEAR PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 48749113756     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000003     Document Type: Article

References (40)

1. Kuriki K and Tajima K: The increasing incidence of colorectal cancer and the preventive strategy in Japan. Asian Pac J Cancer Prev 7: 495-501, 2006.
2. Mori T: New general rules on cancer of the colon, rectum and anus. Geka 9: 1030-1036, 2006. (in Japanese).
3. O'Connell JB, Maggard MA and Ko CY: Colon cancer survival rates with the new American Joint Committee on Cancer Sixth Edition Staging. J Natl Cancer Inst 96: 1420-1425, 2004.
4. Nishitani H and Lygerou Z: Control of DNA replication licensing in a cell cycle. Genes Cells 7: 523-534, 2002.
5. Ishimi Y: A DNA helicase activity is associated with an MCM4, -6, and -7 protein complex. J Biol Chem 272: 24508-24513, 1997.
6. Forsburg SL: Eukaryotic MCM proteins: beyond replication initiation. Microbiol Mol Biol Rev 68: 109-131, 2004.
7. Tye BK and Chang VK: Dual functional regulators coordinate DNA replication and gene expression in proliferating cells. Front Biosci 9: 2548-2555, 2004.
8. Sterner JM, Dew-Knight S, Musahl C, Kornbluth S and Horowitz JM: Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. Mol Cell Biol 18: 2748-2757, 1998.
9. Gonzalez MA, Pinder SE, Callagy G, et al: Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol 21: 4306-4313, 2003.
10. Brake T, Connor JP, Petereit DG and Lambert PF: Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Cancer Res 63: 8173-8180, 2003.
11. Hashimoto K, Araki K, Osaki M, et al: MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications. Pathobiology 71: 193-200, 2004.
12. Padmanabhan V, Callas P, Philips G, Trainer TD and Beatty BG: DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer. J Clin Pathol 57: 1057-1062, 2004.
13. Dudderidge TJ, Stoeber K, Loddo M, et al: Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res 11: 2510-2517, 2005.
14. Dudderidge TJ, McCracken SR, Loddo M, et al: Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer. Br J Cancer 96: 1384-1393, 2007.
15. Wharton SB, Maltby E, Jellinek DA, et al: Subtypes of oligodendroglioma defined by 1p, 19q deletions, differ in the proportion of apoptotic cells but not in replication-licensed non-proliferating cells. Acta Neuropathol (Berl) 113: 119-127, 2007.
16. Honeycutt KA, Chen Z, Koster MI, et al: Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Oncogene 25: 4027-4032, 2006.
17. Ha SA, Shin SM, Namkoong H, et al: Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res 10: 8386-8395, 2004.
18. Isola JJ, Helin HJ, Helle MJ and Kallioniemi OP: Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis and mitotic count. Cancer 65: 1180-1184, 1990.
19. Stoeber K, Tlsty TD, Happerfield L, et al: DNA replication licensing and human cell proliferation. J Cell Sci 114: 2027-2041, 2001.
20. Eward KL, Obermann EC, Shreeram S, et al: DNA replication licensing in somatic and germ cells. J Cell Sci 117: 5875-5886, 2004.
21. Freeman A, Morris LS, Mills AD, et al: Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 5: 2121-2132, 1999.
22. Davies RJ, Freeman A, Morris LS, et al: Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet 359: 1917-1919, 2002.
23. Scott IS, Morris LS, Bird K, et al: A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer. J Pathol 201: 187-197, 2003.
24. Kodani I, Shomori K, Osaki M, Kuratate I, Ryoke K and Ito H: Expression of minichromosome maintenance 2 (MCM2), Ki67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa. Pathobiology 69: 150-158, 2001.
25. Japanese Society for Cancer of the Colon and Rectum (eds): The general rules for clinical and pathological studies on cancer of the colon, rectum and anus. 7th edition. Tokyo, Kanehara & Co., Ltd. Tokyo, pp21-34, 2006.
26. Kaplan EL and Meier P: Non-parametric estimation for incomplete observation. J Am Stat Assoc 53: 457-481, 1958.
27. Cox DR: Regression models and life tables. J R Stat Soc B 34: 187-220, 1972.
28. Palmqvist R, Sellberg P, Oberg A, Tavelin B, Rutegard JN and Stenling R: Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers. Br J Cancer 79: 577-581, 1999.
29. Salminen E, Palmu S, Vahlberg T, Roberts PJ and Soderstrom KO: Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. World J Gastroenterol 11: 3245-3249, 2005.
30. Eisenman RN: Deconstructing myc. Genes Dev 15: 2023-2030, 2001.
31. Fernandez PC, Frank SR, Wang L, et al: Genomic targets of the human c-Myc protein. Genes Dev 17: 1115-1129, 2003.
32. Shohet JM, Hicks MJ, Plon SE, et al: Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Cancer Res 62: 1123-1128, 2002.
33. Williams GH, Romanowski P, Morris L, et al: Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci USA 95: 14932-14937, 1998.
34. Chatrath P, Scott IS, Morris LS, et al: Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. Br J Cancer 89: 1048-1054, 2003.
35. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
36. Jordan CT, Guzman ML and Noble M: Cancer stem cells. N Engl J Med 355: 1253-1261, 2006.
37. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110, 2007.
38. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al: Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115, 2007.
39. Dalerba P, Dylla SJ, Park IK, et al: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104: 10158-10163, 2007.
40. Maslov AY, Bailey KJ, Mielnicki LM, et al: Stem/progenitor cell-specific enhanced green fluorescent protein expression driven by the endogenous Mcm2 promoter. Stem Cells 25: 132-138, 2007.